Macrophage-specific MyD88 deletion and pharmacological inhibition prevents liver damage in non-alcoholic fatty liver disease via reducing inflammatory response-Reference-Cited by-同舟云学术

Macrophage-specific MyD88 deletion and pharmacological inhibition prevents liver damage in non-alcoholic fatty liver disease via reducing inflammatory response

Published:2022-10 Issue:10 Volume:1868 Page:166480
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Yang Bin,Luo Wu,Wang Minxiu,Tang Yelin,Zhu Weiwei,Jin Leiming,Wang Meihong,Wang Yi,Zhang Yi,Zuo Wei,Huang Li-jiang,Zhao Yunjie,Liang Guang

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference53 articles.

1. Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease;Sanyal;Nat. Clin. Pract. Gastroenterol. Hepatol.,2005

2. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018

3. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease;Estes;Hepatology,2018

4. NASH: thiazolidinediones for NASH–one pill doesn't fix everything;Neuschwander-Tetri;Nat. Rev. Gastroenterol. Hepatol. Hepatol.,2010

5. Tissue-resident macrophages: then and now;Davies;Immunology,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding Macrophage Complexity in Metabolic Dysfunction-Associated Steatotic Liver Disease: Transitioning from the M1/M2 Paradigm to Spatial Dynamics;Livers;2024-09-13

2. Imperative role of adaptor proteins in macrophage toll-like receptor signaling pathways;Future Science OA;2024-09-09

3. Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy;Frontiers in Cell and Developmental Biology;2024-09-05

4. METTL14 downregulation drives S100A4+ monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression;Signal Transduction and Targeted Therapy;2024-04-17

5. Macrophage-specific FGFR1 deletion alleviates high-fat-diet-induced liver inflammation by inhibiting the MAPKs/TNF pathways;Acta Pharmacologica Sinica;2024-01-26